SYSTM Wealth Solutions LLC Decreases Stock Position in Sanofi (NASDAQ:SNY)

SYSTM Wealth Solutions LLC decreased its position in shares of Sanofi (NASDAQ:SNY) by 95.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,107 shares of the company’s stock after selling 42,643 shares during the period. SYSTM Wealth Solutions LLC’s holdings in Sanofi were worth $102,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. POM Investment Strategies LLC bought a new stake in Sanofi in the 2nd quarter worth approximately $25,000. Frazier Financial Advisors LLC purchased a new position in shares of Sanofi in the fourth quarter valued at $28,000. Register Financial Advisors LLC bought a new stake in Sanofi in the first quarter worth $29,000. Larson Financial Group LLC raised its stake in Sanofi by 480.8% during the first quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock valued at $29,000 after purchasing an additional 500 shares in the last quarter. Finally, Johnson Financial Group Inc. bought a new position in Sanofi during the fourth quarter valued at $31,000. 10.04% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on SNY shares. StockNews.com cut shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, September 11th. Argus upped their price objective on Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Finally, Citigroup upgraded Sanofi to a “strong-buy” rating in a report on Tuesday. Three investment analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Sanofi currently has an average rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Stock Up 1.4 %

Shares of NASDAQ SNY opened at $58.26 on Friday. Sanofi has a 1 year low of $42.63 and a 1 year high of $58.97. The firm has a 50-day simple moving average of $54.08 and a two-hundred day simple moving average of $50.35. The company has a market cap of $147.56 billion, a P/E ratio of 29.28, a PEG ratio of 1.62 and a beta of 0.60. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, July 25th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.88 by $0.05. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. The firm had revenue of $10.75 billion during the quarter, compared to analyst estimates of $16.86 billion. During the same period last year, the company earned $0.95 EPS. Sanofi’s quarterly revenue was up 7.8% compared to the same quarter last year. Research analysts anticipate that Sanofi will post 4.25 earnings per share for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.